Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
0.98€
-0.158 (-13.86%)
At Close: May 16, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Groupe Actiplay SA

Groupe Actiplay SA Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emerge... ALACT.PA Profile

Golden Star

Ticker Date Change Price
CME May 14 0.92% $210.80
VGIT May 14 0.363% $57.83
VCLT May 14 1.14% $75.73
BNDX May 14 0.535% $48.60
FIXD May 14 0.583% $42.89
OKTA May 14 2.91% $97.89
BND May 14 0.475% $71.65
IEF May 14 0.560% $92.88
LNG May 14 0.330% $157.42
MCD May 13 0.81% $271.32
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT